Pharmaceutical composition used for treating diabetes

Abstract

The invention relates to a pharmaceutical composition used for treating diabetes. The pharmaceutical composition is prepared by taking justicidin A, cucurbitacine E, nardosinone, and clerodendrin A as drug substances via mixing. Different dosage forms can be obtained via conventional pharmaceutical technology. Defects of the prior art are avoided; and the pharmaceutical composition is used for treating diabetes.

Description

technical field [0001] The invention belongs to the field of medicine and relates to a pharmaceutical composition for treating diabetes. Background technique [0002] With the aging of the world's population, diabetes has become a common and frequently-occurring disease, and its incidence is on the rise in industrialized countries. According to statistics, there are about 150 million diabetic patients in the world, 80% of which are non-insulin-dependent diabetes (type 2), of which there are about 30 million in my country. The number of deaths caused by diabetes complications ranks third after cardiovascular and cerebrovascular diseases and cancer in developed countries, which has attracted great attention from all over the world, and researches on the pathogenesis and drug prevention and treatment of diabetes have been carried out one after another. Since the etiology of type 1 diabetes is basically clear, only insulin supplementation is enough, while type 2 diabetes is mor...

AI Technical Summary

Problems solved by technology

Although western medicine emerges in an endless stream, it cannot fundamentally solve the problem, and western medicine treatment has certain side effects and "treatment failure"